NeuroLife is an open access, online, peer reviewed journal published by Medical Sciences Publications (MedSci), LLC in Germany from January, 2022. The publication frequency of NeuroLife is continuous. All articles will be published immediately after acceptance under one VOLUME annually. NeuroLife dedicated to publish good quality of research work in all areas of Basic and Clinical Neuroscience.
Journal Topics:
All areas of Basic and Clinical Neuroscience: Neurobiology, Behavioral Neuroscience, Cellular & Molecular Neuroscience, Cognitive Neuroscience, Neuroanatomy, Neuropharmacology, Neurophysiology, Neurochemistry, Neurodevelopment, Neurotoxicology, Neuroendocrine, Neuropsychiatric Diseases, Neurodegenerative Diseases, Neurogenesis, Neurorehabilitation, Neurogenetics, Neuroimaging, Neuropathology, Neurosurgery, Neurotechnology & Computational Neuroscience.
Article formats
Letter to Editor, Short Communication, Review Articles and Original Research Articles
NeuroLife is a principle member and subscribes to the International Committee of Medical Journal Editors and World Association of medical Editors. We follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by International Committee for Medical Journal Editors (ICMJE), as well as the Committee on Publication Ethics (COPE) code of conduct for editors. The ethical policy of NeuroLife is based on the Committee on Publication Ethics (COPE) guidelines and complies with International Committee of Medical Journal Editors (ICMJE) codes of conduct. The following guidelines should be read in line with the journal’s guide for authors. Readers, authors, reviewers and editors should follow these ethical policies once working with NeuroLife.